IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 51-75 out of 1424.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

Public Release: 20-Jul-2016
eLife
Disturbances in blood cell gene transcription may lead to leukemia
Researchers have succeeded in shedding light on the pathogenesis of DNA breakpoints that are associated with leukemia. A mechanism discovered in a recent study can explain up to 90 percent of DNA damages present in the most common type of leukemia in children. The study was carried out by the University of Eastern Finland and the University of Tampere, and the findings were published in eLife.
Emil Aaltonen Foundation, Jane and Aatos Erkko Foundation, Finnish Cancer Foundation, Finnish Cultural Foundation, Finnish Paediatric Research Foundation, Academy of Finland, University of Eastern Finland, University of Tampere

Contact: Merja Heinäniemi
merja.heinaniemi@uef.fi
358-403-553-842
University of Eastern Finland

Public Release: 20-Jul-2016
Nature
Uncovering a new principle in chemotherapy resistance in breast cancer
A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
NIH/National Cancer Institute

Contact: NCI Media Relations
ncipressofficers@mail.nih.gov
301-496-6641
NIH/National Cancer Institute

Public Release: 20-Jul-2016
Scientific Reports
Liquid biopsies offer hope for earlier treatment, better tracking of ovarian cancer
Researchers at the Mayo Clinic Center for Individualized Medicine have found a promising new way to monitor and treat recurrence of ovarian cancer -- a hard-to-detect disease that claims many lives. New research from George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, finds liquid biopsies from blood tests and DNA sequencing can detect a return of ovarian cancer long before a tumor reappears.

Contact: Susan Buckles
newsbureau@mayo.edu
507-284-5005
Mayo Clinic

Public Release: 20-Jul-2016
Journal of Investigative Dermatology
New sun cream compound offers unprecedented protection against UVA radiation
A new wonder compound developed by University of Bath scientists in collaboration with King's College London offers unprecedented protection against the harmful effects of UVA radiation in sunlight, which include photo-ageing, cell damage and cancer.
Biotechnology and Biological Sciences Research Council

Contact: Chris Melvin
c.m.melvin@bath.ac.uk
44-012-253-83941
University of Bath

Public Release: 20-Jul-2016
BMJ
Imaging after thyroid cancer treatment does not necessarily mean better outcomes
More imaging after thyroid cancer treatment identifies recurrence, but it does not always improve survival, a new study suggests.
NIH/National Cancer Institute, Punya Foundation for Thyroid Cancer Research

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 20-Jul-2016
The BMJ
Study raises concerns over unnecessary imaging after thyroid cancer
A marked rise in use of imaging tests after thyroid cancer has been associated with increased treatment for recurrence, but no clear improvement in survival from the disease, finds a study in The BMJ today.

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ

Public Release: 20-Jul-2016
Nanomedicine: Nanotechnology, Biology, and Medicine
Nanoparticle versus cancer
The Lomonosov Moscow State University researchers in collaboration with their German colleagues have succeeded in proving that silicon nanoparticles can be applied to diagnose and cure cancer.

Contact: Vladimir Koryagin
science-release@rector.msu.ru
Lomonosov Moscow State University

Public Release: 20-Jul-2016
Cell Stem Cell
Cancer stem cells in 'robbers cave' may explain poor prognosis for obese patients
University of Colorado Cancer Center study published in the journal Cell Stem Cell offers a compelling hypothesis explaining poor prognosis for obese cancer patients: researchers found that leukemia stem cells "hide" in fatty tissue, even transforming this tissue in ways that support their survival when challenged with chemotherapy.
NIH/National Cancer Institute, National Institutes of Health

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Anschutz Medical Campus

Public Release: 19-Jul-2016
Prostate Cancer and Prostatic Diseases
Metastatic prostate cancer cases skyrocket
The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, reports a new study. The report considers whether a recent trend of fewer men being screened may be contributing to the rise, or whether the disease has become more aggressive -- or both. The highest increase is among men ages 55 to 69, who could benefit the most from screening and early treatment.
National Institutes of Health, Prostate Cancer Foundation

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University

Public Release: 19-Jul-2016
JAMA
IVF treatment not associated with increased risk of breast cancer
Among women undergoing fertility treatment in the Netherlands between 1980 and 1995, the use of in vitro fertilization compared with non-IVF treatment was not associated with increased risk of breast cancer after a median follow-up of 21 years, according to a study appearing in the July 19 issue of JAMA.

Contact: Nadine Böke
n.boke@nki.nl
The JAMA Network Journals

Public Release: 19-Jul-2016
Radiology
Radiologists do not face elevated risk of radiation-related mortality
Radiologists who graduated from medical school after 1940 do not face an increased risk of dying from radiation-related causes like cancer, according to a new study. Researchers said the findings point to the success of efforts to reduce occupational radiation doses over the past several decades.
National Institutes of Health

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 19-Jul-2016
Lancet Gastroenterology and Hepatology
Rare mutations in bowel cancer may identify patients with a better prognosis
A study focused on colorectal cancers and examined the presence of mutations in a gene that is essential for the accurate copying of DNA when cells divide, known as DNA polymerase epsilon (POLE). As a consequence of the defects in copying their DNA, these tumors accumulate a much higher number of additional mutations than other bowel cancers -- a characteristic that may explain an apparently enhanced immune response against them.
Cancer Research UK, European Union Seventh Framework Programme, European Research Council, Oxford NIHR Biomedical Research Centre, Wellcome Trust, Dutch Digestive Foundation, Netherlands Organisation for Scientific Research

Contact: Tom Calver
news.office@admin.ox.ac.uk
44-186-527-0046
University of Oxford

Public Release: 19-Jul-2016
CA: A Cancer Journal for Clinicians
American Cancer Society endorses HPV vaccine recommendations from CDC
The American Cancer Society has updated its HPV prevention guideline to vaccinate males as well as females at ages 11 to 12.
American Cancer Society

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society

Public Release: 19-Jul-2016
Gut
Lower risk of bowel cancer death linked to high omega 3 intake after diagnosis
A high dietary intake of omega 3 fatty acids, derived from oily fish, may help to lower the risk of death from bowel cancer in patients diagnosed with the disease, suggests research published online in the journal Gut.

Contact: Caroline White
cwhite@bmj.com
44-798-080-0465
BMJ

Public Release: 19-Jul-2016
Prostate Cancer and Prostatic Diseases
Prostate cancer: should screening test procedures be tightened again?
The number of new cases of men suffering from metastatic prostate cancer has risen significantly in a decade's time, and is 72 percent greater in the year 2013 compared to 2004. This is according to the authors Adam Weiner and Edward Schaeffer of Northwestern University Feinberg School of Medicine in the US. Their findings are published in Springer Nature's journal Prostate Cancer and Prostatic Diseases.
Prostate Cancer Foundation

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer

Public Release: 19-Jul-2016
Journal of the American Academy of Dermatology
Many skin cancer patients still too likely to sunburn
A recent study by researchers at Johns Hopkins concludes that a substantial number of people with a history of the most frequent kind of nonmelanoma skin cancers still get sunburned at the same rate as those without previous history, probably because they are not using sun-protective methods the right way or in the right amounts.
Johns Hopkins Department of Dermatology, Johns Hopkins University School of Medicine, National Institutes of Health, and others

Contact: Taylor Graham
tgraha10@jhm.edu
443-287-8560
Johns Hopkins Medicine

Public Release: 19-Jul-2016
New England Journal of Medicine
New treatment developed to prevent nausea, vomiting caused by chemo
A drug that blocks neurotransmitters could reduce nausea and vomiting caused by chemotherapy, research co-authored by a Sanford Health physician and published in the New England Journal of Medicine finds.
NIH/National Cancer Institute

Contact: Tim Gerszewski
timothy.gerszewski@sanfordhealth.org
605-366-2432
Sanford Health/Sanford Research

Public Release: 19-Jul-2016
Cancer Research UK boosts efforts to overcome deadliest cancer as rates climb
CANCER RESEARCH UK has tripled its investment in pancreatic cancer, one of the hardest cancers to treat, since launching its research strategy in 2014 according to new figures published today (Wednesday).
Cancer Research UK

Contact: Emily Head
emily.head@cancer.org.uk
020-346-96189
Cancer Research UK

Public Release: 18-Jul-2016
Journal of Clinical Oncology
Simple measures reduce risk of death in cancer patients in ICU
Daily meetings between physicians, implementation of care protocols and the presence of pharmacists are associated with increase in survival rates in ICUs.

Contact: Marcio Soares
marciosoaresms@gmail.com
D'Or Institute for Research and Education

Public Release: 18-Jul-2016
Journal of Clinical Oncology
Some adolescent cancer survivors may require more comprehensive mental health screening
Research from the Childhood Cancer Survivors Study has identified distinct profiles of psychological symptoms in adolescent cancer survivors; a finding that is expected to advance mental health screening and treatment.
NIH/National Cancer Institute, ALSAC

Contact: Jann Ingmire
Jann.Ingmire@STJUDE.ORG
901-356-5716
St. Jude Children's Research Hospital

Public Release: 18-Jul-2016
Proceedings of the National Academy of Sciences
Bugs' flair for foraging inspires quest for new smart therapies
Fresh insight into how ocean bacteria search for food could aid the development of a new generation of bacterial therapies programmed to treat disease.

Contact: Catriona Kelly
Catriona.Kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh

Public Release: 18-Jul-2016
Clinical Oncology
Genetic cause of 15 percent of colorectal cancer diagnoses identified
Up to 15 percent of colorectal cancers show a genetic mutation known as DNA mismatch repair deficiency, or dMMR. Until now, little has been known about how the mutation behaves in rectal cancer patients, what causes dMMR, and which treatments may be most effective.

Contact: Ron Gilmore
rlgilmore1@mdanderson.org
713-745-1898
University of Texas M. D. Anderson Cancer Center

Public Release: 18-Jul-2016
Journal of Cancer Education
How to decide if watchful waiting is the right choice
A new tool helps remove the emotion around choosing the right approach for prostate cancer.

Contact: Edyta Zielinska
edyta.zielinska@jefferson.edu
215-955-5291
Thomas Jefferson University

Public Release: 18-Jul-2016
Cancer Immunology Research
Genetic drivers of immune response to cancer discovered through 'big data' analysis
Scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified over 100 new genetic regions that affect the immune response to cancer. The findings, published in Cancer Immunology Research, could inform the development of future immunotherapies -- treatments that enhance the immune system's ability to kill tumors.
National Institutes of Health

Contact: Kristen Cusato
kcusato@sbpdiscovery.org
858-795-5126
Sanford-Burnham Prebys Medical Discovery Institute

Public Release: 18-Jul-2016
Proceedings of the National Academy of Sciences
New method of calculating protein interaction to speed up drug development
Incorrect behavior of proteins in cells is a cause of many dangerous illnesses, such as cancer or the Alzheimer's disease. Understanding protein-protein interactions is essential for finding the cure to them. Scientists from MIPT have created a new method to predict possible protein configurations in cells, which is a hundred times faster than any of the previously developed algorithms. This fact makes the algorithm a viable substitution to an experimental approach.
Ministry of Education and Science of the Russian Federation

Contact: Sergey Divakov
divakov@phystech.edu
Moscow Institute of Physics and Technology

Showing releases 51-75 out of 1424.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

  Search News Releases

     

 

EurekAlert!